Infectious Agents and Cancer

unofficial impact factor 2.33

This article is part of the supplement: Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Open Access Oral presentation

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

M Bruyand*, R Thiebaut, F Dabis, S Lawson-Ayayi, P Joly, AJ Sasco, P Mercie, JL Pellegrin, S Geffard, D Neau, P Morlat, G Chene, F Bonnet and the Goupe D'Epidemiologie Clinique Du Sida En Aquitaine (GECSA)

  • * Corresponding author: M Bruyand

Infectious Agents and Cancer 2009, 4(Suppl 2):O3 doi:10.1186/1750-9378-4-S2-O3

No comments have yet been made on this article.

Post a comment